Clinical trial

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

NCT07716176

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-12

PhasePHASE3

Study timeline

Study start (actual)2025-12-12Date precision: day

Registry last updated2026-07-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Nausea and Vomiting Caused by Chemotherapyunresolved

Interventions

Auricular point stimulation plus dexamethasoneDRUG

Standard pharmacologic antiemetic regimenDRUG

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

Mapped research locations

HangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07716176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.